Mark For: ENDOTAG™ trademark registration is intended to cover the categories of
Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 76677125 |
Mark Literal Elements | ENDOTAG |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | TRADEMARK |
Register | PRINCIPAL |
Current Location | INTENT TO USE SECTION 2008-10-30 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | Yes |
Current Use | No |
Intent To Use | Yes |
Filed ITU | No |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Adrienne L. White |
Law Office Assigned | M50 |
Employee Name | VERHOSEK, WILLIAM T |
2005-05-27 | Application Filed |
2008-03-18 | Published |
2008-03-18 | Published for Opposition |
2008-10-30 | Location: INTENT TO USE SECTION |
2011-01-10 | Abandon |
2011-01-10 | Status: Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all docume |
2011-01-10 | Status: Dead/Abandoned |
2018-07-08 | Transaction Date |
Party: | ![]() |
Address | Lochhamer Strasse 11 82152 Planegg/Martinsried FED REP GERMANY |
Legal Entity Type | Aktiengesellschaft |
Legal Entity State | FED REP GERMANY |
![]() | 2007-05-15 | |
![]() | 2007-05-15 | |
![]() | 2007-06-04 | |
![]() | 2007-06-05 | |
![]() | 2007-06-05 | |
![]() | 2007-12-06 | |
![]() | 2008-01-18 | |
![]() | 2008-01-26 | |
![]() | 2008-01-29 | |
![]() | 2008-01-29 | |
![]() | 2008-02-14 | |
![]() | 2008-02-27 | |
![]() | 2008-06-10 | |
![]() | 2008-10-28 | |
![]() | 2008-10-31 | |
![]() | 2008-10-31 | |
![]() | 2009-05-12 | |
![]() | 2009-05-15 | |
![]() | 2009-05-15 | |
![]() | 2009-09-29 | |
![]() | 2009-12-02 | |
![]() | 2009-12-08 | |
![]() | 2009-12-08 | |
![]() | 2010-06-02 | |
![]() | 2010-06-08 | |
![]() | 2010-06-08 | |
![]() | 2011-01-10 | |
![]() | 2011-01-11 |
(ABANDONED)
IC 005. US 006 018 044 046 051 052. G & S: Medicines for humans and animals in the form of serums and diagnostic preparations for medical purposes and therapeutic use, namely, medicines for treating tumorous diseases such as gliomas, carcinomas of the colon, ovarian carcinomas, cervical carcinomas, carcinomas of the prostate, melanomas, basal cell carcinomas, actinic keratosis, breast cancers, bone cancers, brain cancers, colon cancers, endocrine system cancers, gastrointestinal cancers, gynaecological cancers, head and neck cancers, leukemias, lung cancers, lymphomas, metastases, myelomas, pediatric cancers, penile cancers, sarcomas, skin cancers, testicular cancers, thyroid cancers, urinary tract cancers, pleural cancers, neuronal cancers, mesotheliomas, astrocytomas, oligodendrogliomas, meningiomas, neurofibromas, glioblastomas, ependymomas, schwannomas, neurofibrosarcomas, neuroblastomas, pituitary gland cancers, cancers of the hypophysis, medulloblastomas, renal cell carcinomas, pancreatic cancers, gastric cancers, bladder cancers, liver cancers, prostate cancer, fibrosarcomas, squamous cell carcinomas, neuroectodermal cancers, hodgkin's lymphomas, non-hodgkin's lymphomas, hepatomas, epidermal carcinomas, or medicines for treating chronic inflammatory diseases such as rheumatoid arthritis, autoimmune diseases, allergies, multiple sclerosis; medicines for stimulating wound healing; medicines for treating eye diseases and arteriosclerosis; medicines for treating cardiovascular illnesses, namely, hyperlipidaemia, coronary heart diseases and cardiac insufficiency; medicines for treating skin diseases, namely, warts, genital warts and herpes; excluding medicines for enemas and for the preparation of a coloscopy
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Medicines for humans and animals in the form of serums and diagnostic preparations for medical purposes and therapeutic use, namely, medicines for treating tumorous diseases such as gliomas, carcinomas of the colon, ovarian carcinomas, cervical carcinomas, carcinomas of the prostate, melanomas, basal cell carcinomas, actinic keratosis, breast cancers, bone cancers, brain cancers, colon cancers, endocrine system cancers, gastrointestinal cancers, gynaecological cancers, head and neck cancers, leukemias, lung cancers, lymphomas, metastases, myelomas, pediatric cancers, penile cancers, sarcomas, skin cancers, testicular cancers, thyroid cancers, urinary tract cancers, pleural cancers, neuronal cancers, mesotheliomas, astrocytomas, oligodendrogliomas, meningiomas, neurofibromas, glioblastomas, ependymomas, schwannomas, neurofibrosarcomas, neuroblastomas, pituitary gland cancers, cancers of the hypophysis, medulloblastomas, renal cell carcinomas, pancreatic cancers, gastric cancers, bladder cancers, liver cancers, prostate cancer, fibrosarcomas, squamous cell carcinomas, neuroectodermal cancers, hodgkin's lymphomas, non-hodgkin's lymphomas, hepatomas, epidermal carcinomas, or medicines for treating chronic inflammatory diseases such as rheumatoid arthritis, autoimmune diseases, allergies, multiple sclerosis; medicines for stimulating wound healing; medicines for treating eye diseases and arteriosclerosis; medicines for treating cardiovascular illnesses, namely, hyperlipidaemia, coronary heart diseases and cardiac insufficiency; medicines for treating skin diseases, namely, warts, genital warts and herpes; excluding medicines for enemas and for the preparation of a coloscopy |
Description | Date | Proceeding Number |
---|---|---|
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | 2011-01-10 | |
ABANDONMENT - NO USE STATEMENT FILED | 2011-01-10 | 99999 |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2010-06-08 | |
SOU EXTENSION 4 GRANTED | 2010-06-07 | 69302 |
TEAS EXTENSION RECEIVED | 2010-06-02 | |
SOU EXTENSION 4 FILED | 2010-06-02 | 69302 |
SOU EXTENSION 3 GRANTED | 2009-12-07 | 69302 |
TEAS EXTENSION RECEIVED | 2009-12-02 | |
SOU EXTENSION 3 FILED | 2009-12-02 | 69302 |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2009-09-29 | |
SOU EXTENSION 2 GRANTED | 2009-05-14 | 69302 |
TEAS EXTENSION RECEIVED | 2009-05-12 | |
SOU EXTENSION 2 FILED | 2009-05-05 | 69302 |
SOU EXTENSION 1 GRANTED | 2008-10-30 | 69302 |
CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2008-10-29 | 69302 |
TEAS EXTENSION RECEIVED | 2008-10-28 | |
SOU EXTENSION 1 FILED | 2008-10-28 | 69302 |
NOA MAILED - SOU REQUIRED FROM APPLICANT | 2008-06-10 | |
PUBLISHED FOR OPPOSITION | 2008-03-18 | |
NOTICE OF PUBLICATION | 2008-02-27 | |
LAW OFFICE PUBLICATION REVIEW COMPLETED | 2008-02-13 | 76243 |
EXAMINERS AMENDMENT MAILED | 2008-01-28 | |
EXAMINERS AMENDMENT -WRITTEN | 2008-01-26 | 77304 |
EXAMINER'S AMENDMENT ENTERED | 2008-01-26 | 88888 |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2008-01-26 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2008-01-17 | 76243 |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2008-01-17 | 76243 |
ASSIGNED TO LIE | 2008-01-17 | 76243 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2007-12-06 | |
NON-FINAL ACTION MAILED | 2007-06-06 | |
NON-FINAL ACTION WRITTEN | 2007-06-05 | 77304 |
APPLICATION FILING RECEIPT MAILED | 2007-06-05 | |
ASSIGNED TO EXAMINER | 2007-06-01 | 77304 |
NEW APPLICATION ENTERED IN TRAM | 2007-05-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.